Unichem Laboratories Limited Stock: price and insider trades · India
Unichem Laboratories Limited: what insiders have been doing
Every trade that managers of Unichem Laboratories Limited disclose to SEBI (PIT + SAST) is tracked on this page. The company sits in the Health Care sector. From 26 October 2025 to 26 October 2026, the disclosure feed for Unichem Laboratories Limited logged 1 filing by 1 insider.
Only sales appear on the open market, 1 sale in all, filed by 1 insider. No amount is published for 1 filing, which the totals therefore leave out.
Across the 1,893 companies tracked on its exchange, the median is 4 filings; at 1 filing, this issuer sits below that mark. The full history, which starts in 2023, counts no purchases against 25 sales.
A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 300,000 shares-MarketSEBI:6058b8145ac4ac98a7b2ded4a0955eba73078be1
- 13,200 shares@ ₹440.00100.0% of flowEquity SharesSEBI:7879154319728b3aae9708a12aaffcd5331774b5
- 4,000 shares@ ₹440.00100.0% of flowEquity SharesSEBI:41be565942f439d8d7af9b3d7f2a25c417030981
- 4,646 shares@ ₹440.00100.0% of flowEquity SharesSEBI:6bccd3c9bf71ed651de661ad3fd7b8c8633c5879
- 13,579,571 shares@ ₹440.6111100.0% of flowEquity SharesSEBI:2bade3da02c1474704e1ae6585050890cb4bf287
- 5,000 shares@ ₹408.21926.8% of flowEquity SharesSEBI:fda54853fbb6bb8574ba16d243dec98c30ae1dd4
- 6,000 shares@ ₹406.74100.0% of flowEquity SharesSEBI:69d0d54c9c3c1b1222edc8be9c0f1fbc1eb8b6a6
- 5,000 shares@ ₹407.406.8% of flowEquity SharesSEBI:6a662fbde7fb3192514f8643c58d4e51740e62a8
- 3,339 shares@ ₹401.6442100.0% of flowEquity SharesSEBI:ed84f7af144a0e8dfa42da4f1117376a7129f775
- 30,000 shares@ ₹404.4440.1% of flowEquity SharesSEBI:7730efabd04212480f2bb72e471f9cd6a685163c
- 16,259 shares@ ₹397.002221.4% of flowEquity SharesSEBI:476237d8914b280de2e5c1e84006dedc78160967
- 23,501,440 shares@ ₹402.25100.0% of flowEquity SharesSEBI:a5fa25069ebd61d430e5d1c63abe50c43e2b2cd3
- 19,000 shares@ ₹397.028925.0% of flowEquity SharesSEBI:6deb3b8d0750e7e3fb4d1cb1f4e33fce986956fc
- 3,029 shares@ ₹378.5497100.0% of flowEquity SharesSEBI:3032236cf7cd95f3b60d756f88fb2565025a99b9
- 2,836 shares@ ₹378.1298100.0% of flowEquity SharesSEBI:fec9a6aa4709d8bd7d35712d0c2fcd8a5134ed01
- 2,000 shares@ ₹378.07516.5% of flowEquity SharesSEBI:ae47dc946e83441a2cb6f80b2a5066409f9dffd2
- 4,000 shares@ ₹378.1119.4% of flowEquity SharesSEBI:480b01ecf9027de5ba5f57f04ffb6510305f9679
- 1,000 shares@ ₹377.068.2% of flowEquity SharesSEBI:ef312888cc19cdd69327b059a921455e64b0be2b
- 4,000 shares@ ₹377.48519.2% of flowEquity SharesSEBI:4cef8dbe20d9b369f9d9d154bf1a013062a4f6a5
- 1,000 shares@ ₹377.798.2% of flowEquity SharesSEBI:98330e63419e9cc099f38be1725d3ba544c8024d
- 1,750 shares@ ₹371.8614.7% of flowEquity SharesSEBI:79ac3ff966f9c10b4d22f932ef6778ad0a4042ba
- 2,750 shares@ ₹371.9813.5% of flowEquity SharesSEBI:fe1de7860edb9156960bd48829524db2ea128b14
- 6,312 shares@ ₹372.00100.0% of flowEquity SharesSEBI:e7d568c66a43fa65d642ba9662ccec40722d6639
- 2,800 shares@ ₹371.1613.7% of flowEquity SharesSEBI:55e86fa2f602278b5033c24c15344525ccd8577e
- 1,800 shares@ ₹371.6915.1% of flowEquity SharesSEBI:20708d7ffb7483411c2964227bcd72ae8b2c15ef
25 of 32 declarations
About Unichem Laboratories Limited
Unichem Laboratories Limited is an Indian pharmaceutical company that specializes in the manufacturing of generic drugs and pharmaceutical products. It is listed on the Bombay Stock Exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
